Annual Accounts Receivable
N/A
December 31, 2023
Summary
- ABEO annual accounts receivable is not available.
Performance
ABEO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- ABEO quarterly accounts receivable is not available.
Performance
ABEO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ABEO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ABEO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Abeona Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $3.50 M(>+9900.0%) |
| Sep 2022 | - | $0.00(-100.0%) |
| Jun 2022 | - | $1.00 M(>+9900.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $3.00 M(>+9900.0%) | $3.00 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2020 | - | $7.00 M(>+9900.0%) |
| Sep 2019 | - | $15.00 K(-62.5%) |
| Jun 2019 | - | $40.00 K(+5.3%) |
| Mar 2019 | - | $38.00 K(-53.1%) |
| Dec 2018 | $81.00 K(-24.3%) | $81.00 K(-77.0%) |
| Sep 2018 | - | $352.00 K(+648.9%) |
| Jun 2018 | - | $47.00 K(-26.6%) |
| Mar 2018 | - | $64.00 K(-40.2%) |
| Dec 2017 | $107.00 K(-13.7%) | $107.00 K(-3.6%) |
| Sep 2017 | - | $111.00 K(+14.4%) |
| Jun 2017 | - | $97.00 K(-34.5%) |
| Mar 2017 | - | $148.00 K(+19.4%) |
| Dec 2016 | $124.00 K(+7.8%) | $124.00 K(-79.5%) |
| Sep 2016 | - | $606.00 K(+441.1%) |
| Jun 2016 | - | $112.00 K(-54.1%) |
| Mar 2016 | - | $244.00 K(+112.2%) |
| Dec 2015 | $115.00 K(+228.6%) | $115.00 K(-57.6%) |
| Sep 2015 | - | $271.00 K(-17.9%) |
| Jun 2015 | - | $330.00 K(+129.2%) |
| Mar 2015 | - | $144.00 K(+311.4%) |
| Dec 2014 | $35.00 K(-52.7%) | $35.00 K(+1066.7%) |
| Sep 2014 | - | $3000.00(-94.8%) |
| Jun 2014 | - | $58.00 K(-1.7%) |
| Mar 2014 | - | $59.00 K(-20.3%) |
| Dec 2013 | $74.00 K(-91.2%) | $74.00 K(+32.1%) |
| Sep 2013 | - | $56.00 K(-78.4%) |
| Jun 2013 | - | $259.00 K(-79.0%) |
| Mar 2013 | - | $1.23 M(+46.5%) |
| Dec 2012 | $840.00 K(+152.3%) | $840.00 K(+152.3%) |
| Dec 2011 | $333.00 K | $333.00 K(+0.9%) |
| Sep 2008 | - | $330.00 K(+214.3%) |
| Jun 2008 | - | $105.00 K(-87.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2007 | - | $861.00 K(+313.9%) |
| Jun 2007 | - | $208.00 K(-41.6%) |
| Mar 2007 | - | $356.00 K(-0.8%) |
| Dec 2006 | $359.00 K(-92.0%) | $359.00 K(-92.4%) |
| Sep 2006 | - | $4.71 M(+1.5%) |
| Jun 2006 | - | $4.64 M(+1.7%) |
| Mar 2006 | - | $4.57 M(+1.7%) |
| Dec 2005 | $4.49 M(+5728.6%) | $4.49 M(+486.7%) |
| Sep 2005 | - | $765.00 K(-5.6%) |
| Jun 2005 | - | $810.00 K(+6.0%) |
| Mar 2005 | - | $764.00 K(+892.2%) |
| Dec 2004 | $77.00 K(-93.3%) | $77.00 K(-90.6%) |
| Sep 2004 | - | $819.00 K(-27.4%) |
| Jun 2004 | - | $1.13 M(-5.1%) |
| Mar 2004 | - | $1.19 M(+3.5%) |
| Dec 2003 | $1.15 M(-3.0%) | $1.15 M(+103.4%) |
| Sep 2003 | - | $565.00 K(-43.7%) |
| Jun 2003 | - | $1.00 M(-29.3%) |
| Mar 2003 | - | $1.42 M(+19.9%) |
| Dec 2002 | $1.18 M(+1326.5%) | $1.18 M(+770.6%) |
| Sep 2002 | - | $136.00 K(-76.4%) |
| Jun 2002 | - | $577.00 K(+49.1%) |
| Mar 2002 | - | $387.00 K(+366.3%) |
| Dec 2001 | $83.00 K(-66.9%) | $83.00 K(-57.7%) |
| Sep 2001 | - | $196.00 K(>+9900.0%) |
| Jun 2001 | - | $1000.00(-85.7%) |
| Mar 2001 | - | $7000.00(-97.2%) |
| Dec 2000 | $251.00 K(+151.0%) | $251.00 K(-43.0%) |
| Sep 2000 | - | $440.00 K(+1000.0%) |
| Jun 2000 | - | $40.00 K(-81.1%) |
| Mar 2000 | - | $212.00 K(+112.0%) |
| Dec 1999 | $100.00 K(+9900.0%) | $100.00 K(+3233.3%) |
| Sep 1999 | - | $3000.00(-90.6%) |
| Jun 1999 | - | $32.00 K(+166.7%) |
| Mar 1999 | - | $12.00 K |
| Dec 1997 | $1000.00(0.0%) | - |
| Dec 1996 | $1000.00(-97.9%) | - |
| Dec 1995 | $48.00 K | - |
FAQ
- What is the all time high annual accounts receivable for Abeona Therapeutics?
- What is the all time high quarterly accounts receivable for Abeona Therapeutics?
What is the all time high annual accounts receivable for Abeona Therapeutics?
Abeona Therapeutics all-time high annual accounts receivable is $4.49 M
What is the all time high quarterly accounts receivable for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly accounts receivable is $7.00 M